Skip to main content
Top
Published in: Journal of Cancer Education 1/2019

01-02-2019

Training Needs of Clinical and Research Professionals to Optimize Minority Recruitment and Retention in Cancer Clinical Trials

Authors: Soumya J. Niranjan, Raegan W. Durant, Jennifer A. Wenzel, Elise D. Cook, Mona N. Fouad, Selwyn M. Vickers, Badrinath R. Konety, Sarah B. Rutland, Zachary R. Simoni, Michelle Y. Martin

Published in: Journal of Cancer Education | Issue 1/2019

Login to get access

Abstract

The study of disparities in minority recruitment to cancer clinical trials has focused primarily on inquiries among minority patient populations. However, clinical trial recruitment is complex and requires a broader appreciation of the multiple factors that influence minority participation. One area that has received little attention is minority recruitment training for professionals who assume various roles in the clinical trial recruitment process. Therefore, we assessed the perspectives of cancer center clinical and research personnel on their training and education needs toward minority recruitment for cancer clinical trials. Ninety-one qualitative interviews were conducted at five U.S. cancer centers among four stakeholder groups: cancer center leaders, principal investigators, referring clinicians, and research staff. Interviews were recorded and transcribed. Qualitative analyses focused on response data related to training for minority recruitment for cancer clinical trials. Four prominent themes were identified: (1) Research personnel are not currently being trained to focus on recruitment and retention of minority populations; (2) Training for minority recruitment and retention provides for a specific focus on factors influencing minority research participation; (3) Training on cultural awareness may help to bridge cultural gaps between potential minority participants and research professionals; (4) Views differ regarding the importance of research personnel training designed to focus on recruitment of minority populations. There is a lack of systematic training for minority recruitment. Many stakeholders acknowledged the benefits of minority recruitment training and welcomed training that focuses on increasing cultural awareness to increase the participation of minorities in cancer clinical trials.
Literature
1.
go back to reference Health, U.D.o. and H. Services (1994) NIH guidelines on the inclusion of women and minorities as subjects in clinical research. Fed Regist 59(59):14508–14513 Health, U.D.o. and H. Services (1994) NIH guidelines on the inclusion of women and minorities as subjects in clinical research. Fed Regist 59(59):14508–14513
2.
go back to reference Giuliano AR et al (2000) Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors. Ann Epidemiol 10(8):S22–S34CrossRef Giuliano AR et al (2000) Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors. Ann Epidemiol 10(8):S22–S34CrossRef
3.
go back to reference Scalici J et al (2015) Minority participation in gynecologic oncology group (GOG) studies. Gynecol Oncol 138(2):441–444CrossRef Scalici J et al (2015) Minority participation in gynecologic oncology group (GOG) studies. Gynecol Oncol 138(2):441–444CrossRef
4.
go back to reference Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66(1):7–30CrossRef Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66(1):7–30CrossRef
5.
go back to reference DeSantis CE et al (2016) Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin 66(1):31–42CrossRef DeSantis CE et al (2016) Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin 66(1):31–42CrossRef
6.
go back to reference Ford JG et al (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112(2):228–242CrossRef Ford JG et al (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112(2):228–242CrossRef
7.
go back to reference Howerton MW et al (2007) Provider roles in the recruitment of underrepresented populations to cancer clinical trials. Cancer 109(3):465–476CrossRef Howerton MW et al (2007) Provider roles in the recruitment of underrepresented populations to cancer clinical trials. Cancer 109(3):465–476CrossRef
8.
go back to reference Durant RW et al (2014) Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT). Cancer 120(S7):1097–1105CrossRef Durant RW et al (2014) Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT). Cancer 120(S7):1097–1105CrossRef
9.
go back to reference Rivers D et al (2013) A systematic review of the factors influencing African Americans' participation in cancer clinical trials. Contemp Clin Trials 35(2):13–32CrossRef Rivers D et al (2013) A systematic review of the factors influencing African Americans' participation in cancer clinical trials. Contemp Clin Trials 35(2):13–32CrossRef
10.
go back to reference Germino BB et al (2011) Engaging African American breast cancer survivors in an intervention trial: culture, responsiveness and community. J Cancer Surviv 5(1):82–91CrossRef Germino BB et al (2011) Engaging African American breast cancer survivors in an intervention trial: culture, responsiveness and community. J Cancer Surviv 5(1):82–91CrossRef
11.
go back to reference Robins Sadler G et al (2006) Health parties for African American study recruitment. J Cancer Educ 21(2):71–76CrossRef Robins Sadler G et al (2006) Health parties for African American study recruitment. J Cancer Educ 21(2):71–76CrossRef
12.
go back to reference Jones RA, Steeves R, Williams I (2009) Strategies for recruiting African American men into prostate cancer screening studies. Nurs Res 58(6):452CrossRef Jones RA, Steeves R, Williams I (2009) Strategies for recruiting African American men into prostate cancer screening studies. Nurs Res 58(6):452CrossRef
13.
go back to reference Ford ME, Siminoff LA, Pickelsimer E, Mainous AG, Smith DW, Diaz VA, Soderstrom LH, Jefferson MS, Tilley BC (2013) Unequal burden of disease, unequal participation in clinical trials: solutions from African American and Latino community members. Health Soc Work 38(1):29–38 Ford ME, Siminoff LA, Pickelsimer E, Mainous AG, Smith DW, Diaz VA, Soderstrom LH, Jefferson MS, Tilley BC (2013) Unequal burden of disease, unequal participation in clinical trials: solutions from African American and Latino community members. Health Soc Work 38(1):29–38
14.
go back to reference Ma GX, Tan Y, Blakeney NC, Seals BF, Ma XS, Zhai S, Liu A, Tai Y, Michaels M (2013) The impact of a community-based clinical trial educational intervention among underrepresented Chinese Americans. Cancer Epidemiol Biomark Prev 23(3):424–32 Ma GX, Tan Y, Blakeney NC, Seals BF, Ma XS, Zhai S, Liu A, Tai Y, Michaels M (2013) The impact of a community-based clinical trial educational intervention among underrepresented Chinese Americans. Cancer Epidemiol Biomark Prev 23(3):424–32
15.
go back to reference Anwuri VV et al (2013) An institutional strategy to increase minority recruitment to therapeutic trials. Cancer Causes Control 24(10):1797–1809CrossRef Anwuri VV et al (2013) An institutional strategy to increase minority recruitment to therapeutic trials. Cancer Causes Control 24(10):1797–1809CrossRef
16.
go back to reference Quinn GP et al (2011) Enhancing oncology health care provider's sensitivity to cultural communication to reduce cancer disparities: a pilot study. J Cancer Educ 26(2):322CrossRef Quinn GP et al (2011) Enhancing oncology health care provider's sensitivity to cultural communication to reduce cancer disparities: a pilot study. J Cancer Educ 26(2):322CrossRef
17.
go back to reference Wallington SF et al (2016) Enrolling minority and underserved populations in cancer clinical research. Am J Prev Med 50(1):111–117CrossRef Wallington SF et al (2016) Enrolling minority and underserved populations in cancer clinical research. Am J Prev Med 50(1):111–117CrossRef
18.
go back to reference Betancourt JR et al (2003) Defining cultural competence: a practical framework for addressing racial/ethnic disparities in health and health care. Public Health Rep 118(4):293–302CrossRef Betancourt JR et al (2003) Defining cultural competence: a practical framework for addressing racial/ethnic disparities in health and health care. Public Health Rep 118(4):293–302CrossRef
19.
go back to reference Smith WR et al (2007) Recommendations for teaching about racial and ethnic disparities in health and health care. Ann Intern Med 147(9):654–664CrossRef Smith WR et al (2007) Recommendations for teaching about racial and ethnic disparities in health and health care. Ann Intern Med 147(9):654–664CrossRef
20.
go back to reference Association, W.M (2015) WMA declaration of Geneva. Int J Person Cent Med 4(3):157 Association, W.M (2015) WMA declaration of Geneva. Int J Person Cent Med 4(3):157
21.
go back to reference Nelson AR, AY Stith, and BD Smedley (2003) Unequal treatment: confronting racial and ethnic disparities in health care (full printed version). National Academies Press, Washington Nelson AR, AY Stith, and BD Smedley (2003) Unequal treatment: confronting racial and ethnic disparities in health care (full printed version). National Academies Press, Washington
22.
go back to reference Abernethy A et al (2014) Turning the tide against cancer through sustained medical innovation: the pathway to progress. Clin Cancer Res 20(5):1081–1086CrossRef Abernethy A et al (2014) Turning the tide against cancer through sustained medical innovation: the pathway to progress. Clin Cancer Res 20(5):1081–1086CrossRef
23.
go back to reference Bergenmar M, Johansson H, Wilking N (2011) Levels of knowledge and perceived understanding among participants in cancer clinical trials–factors related to the informed consent procedure. Clin Trials 8(1):77–84CrossRef Bergenmar M, Johansson H, Wilking N (2011) Levels of knowledge and perceived understanding among participants in cancer clinical trials–factors related to the informed consent procedure. Clin Trials 8(1):77–84CrossRef
24.
go back to reference Albrecht TL et al (2008) Influence of clinical communication on patients' decision making on participation in clinical trials. J Clin Oncol 26(16):2666–2673CrossRef Albrecht TL et al (2008) Influence of clinical communication on patients' decision making on participation in clinical trials. J Clin Oncol 26(16):2666–2673CrossRef
25.
go back to reference Durant RW et al (2011) Different types of distrust in clinical research among whites and African Americans. J Natl Med Assoc 103(2):123–130CrossRef Durant RW et al (2011) Different types of distrust in clinical research among whites and African Americans. J Natl Med Assoc 103(2):123–130CrossRef
Metadata
Title
Training Needs of Clinical and Research Professionals to Optimize Minority Recruitment and Retention in Cancer Clinical Trials
Authors
Soumya J. Niranjan
Raegan W. Durant
Jennifer A. Wenzel
Elise D. Cook
Mona N. Fouad
Selwyn M. Vickers
Badrinath R. Konety
Sarah B. Rutland
Zachary R. Simoni
Michelle Y. Martin
Publication date
01-02-2019
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 1/2019
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-017-1261-0

Other articles of this Issue 1/2019

Journal of Cancer Education 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine